Cell Banking Outsourcing Market Size is valued at US$ 14.2 Bn in 2024 and is predicted to reach US$ 65.5 Bn by the year 2034 at an 16.8% CAGR during the forecast period for 2025-2034.
A cell bank is a facility that keeps cells that have been taken from different body fluids and organ tissue in order to meet future demands. The ability to preserve cells with a specific genome for later use is known as cell banking outsourcing. In addition to reducing cross-contamination of a cell line, it can be utilized to generate comprehensive characterizations of cell lines. The main factors propelling the cell banking outsourcing market's growth are the growing need for monoclonal antibodies and efficient biopharmaceuticals, the expanding use of stem cell therapies, and the increasing advancement of cryopreservation and cell bank preparation techniques.
Additionally, large-scale investments in R&D to improve disease treatment, increased stem cell application research, the creation of sophisticated preservation methods, and the adoption of acquisition and collaboration strategies are all anticipated to have an impact on the cell banking outsourcing market growth in the years to come. However, the global market for cell banking outsourcing may be constrained in its expansion over the projected period by the high operating costs of stem cell therapies, the availability of suitable donors, strict regulatory requirements, the risk involved in cell line banking, and ethical considerations.
Some of the Key Players in Cell Banking Outsourcing Market:
· Lonza Group
· AGC Biologics
· BioReliance (Merck KGaA)
· Aldevron
· QTP Labs
· Sino Biological
· BioOutsource (Sartorius)
· Thermo Fisher Scientific (Patheon)
· Vibalogics
· Charles River Laboratories
· Eurofins Scientifi
· Fujifilm Diosynth Biotechnologies
· Cell and Gene Therapy Catapult
· Rentschler Biopharma
· Samsung Biologics
· Novartis Contract Manufacturing
· Paragon Bioservices (Catalent)
· Porton Advanced
· Syngene International
· WuXi Advanced Therapies (WuXi AppTec)
The Cell banking outsourcing market is segmented by service type, cell type, bank type, application, phase, and end-use. By service type, the market is segmented into cell line expansion & banking, cell line characterization & testing, cryopreservation & storage, regulatory support (CMC documentation, release testing), biosafety testing (sterility, mycoplasma, adventitious agents), and others. by cell type, the market is segmented into mammalian cells (CHO cells, BHK cells, VERO cells, HEK 293 cells, others), stem cells (induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), embryonic stem cells (ESCs)), microbial cells (yeast cells, E. coli, others), hybridoma cells, and others (e.g., insect cells, primary cells).
By bank type, the market is segmented into research cell bank (RCB), master cell bank (MCB), end-of-production cell bank (EOPCB), working cell bank (WCB), and others (e.g., parental cell bank, stability cell bank). By application, the market is segmented into vaccine production, cell & gene therapy, tissue engineering, biologics manufacturing, regenerative medicine, research and development, and others. By phase, the market is segmented into preclinical, clinical (phase I, phase II, phase III), and commercial. By end-use, the market is segmented into biopharmaceutical companies, contract development and manufacturing organizations (CDMOs), cell therapy companies, academic & research institutions, and others.
In 2024, the market for cell banking outsourcing was dominated by the cryopreservation & storage segment because cell cryopreservation preserves product efficacy and quality, reduces transportation difficulties, and shields the product from unforeseen shipment delays. Due to inadequate planning or product shelf life it helps save expenses and material waste. By preserving cell viability and functionality until the cells are needed, this procedure increases the product's shelf life and consistency. However, the cell line characterisation and biosafety testing segment is expected to grow at the quickest rate because characterization of cell lines reduces misidentification issues by confirming which are well-defined and appropriate for the planned study.
The master cell banking segment dominated the cell banking outsourcing market in 2024 and is predicted to continue to do so in the years to come due to a number of factors, including the increasing need for cell-based treatments, biologics, and vaccines that depend on a reliable and well-characterized cell line as the starting material, as well as regulatory requirements for cell line authentication, quality control, and traceability that call for the creation of strong master cell banks. The master cell banking category is also expanding at a rapid pace because of the time and money savings that come with outsourcing MCB services, which frees up businesses to concentrate on their core R&D.
In 2024, North America held the largest market share due to the region's significant R&D facilities and the growing number of metabolic diseases like Parkinson's and Alzheimer's, as well as other cancers that can be treated with gene therapy. Another factor contributing to the organizational diversity in the North American healthcare system is the sharp rise in the development of financial services, which is an indication of swift change. Furthermore, North America is a center for cutting-edge research and development in fields including drug discovery, cell therapy, and regenerative medicine, which increases demand for specialist cell banking outsourcing services.
The rapidly growing biotechnology sector and rising investments in healthcare infrastructure are likely to propel the cell banking outsourcing market's growth rate in Asia Pacific over the forecast period. The leading nations in this expansion are China, India, and Japan, which have made notable strides in the study and development of biotechnology. Furthermore, the cell banking outsourcing market expansion in Asia Pacific is being driven by the rising incidence of chronic illnesses, rising demand for biologics, and encouraging government programs that encourage R&D.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 14.2 Bn |
|
Revenue Forecast In 2034 |
USD 65.5 Bn |
|
Growth Rate CAGR |
CAGR of 16.8% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Service Type, By Cell Type, By Bank Type, By Application, By Phase, By End-use, and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; Germany; The UK; France; Italy; Spain; Rest of Europe; China; Japan; India; South Korea; Southeast Asia; Rest of Asia Pacific; Brazil; Argentina; Mexico; Rest of Latin America; GCC Countries; South Africa; Rest of the Middle East and Africa |
|
Competitive Landscape |
Lonza Group, AGC Biologics, BioReliance (Merck KGaA), Aldevron, QTP Labs, Sino Biological, BioOutsource (Sartorius), Thermo Fisher Scientific (Patheon), Vibalogics, Charles River Laboratories, Eurofins Scientifi, Fujifilm Diosynth Biotechnologies, Cell and Gene Therapy Catapult, Rentschler Biopharma, Samsung Biologics, Novartis Contract Manufacturing, Paragon Bioservices (Catalent), Porton Advanced, Syngene International, and WuXi Advanced Therapies (WuXi AppTec) |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Cell Banking Outsourcing Market Snapshot
Chapter 4. Global Cell Banking Outsourcing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Cell Banking Outsourcing Market Industry Trends
4.10. Global Cell Banking Outsourcing Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
Chapter 5. Cell Banking Outsourcing Market Segmentation 1: Bank Type, Estimates & Trend Analysis
5.1. Market Share by Bank Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Bank Type:
5.2.1. Master Cell Bank (MCB)
5.2.2. Working Cell Bank (WCB)
5.2.3. Research Cell Bank (RCB)
5.2.4. End-of-Production Cell Bank (EOPCB)
5.2.5. Others (e.g., Parental Cell Bank, Stability Cell Bank)
Chapter 6. Cell Banking Outsourcing Market Segmentation 2: By Cell Type, Estimates & Trend Analysis
6.1. Market Share by Cell Type, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Cell Type:
6.2.1. Mammalian Cells
6.2.1.1. CHO Cells
6.2.1.2. HEK 293 Cells
6.2.1.3. Vero Cells
6.2.1.4. BHK Cells
6.2.1.5. Others
6.2.2. Microbial Cells
6.2.2.1. E. coli
6.2.2.2. Yeast Cells
6.2.2.3. Others
6.2.3. Stem Cells
6.2.3.1. Induced Pluripotent Stem Cells (iPSCs)
6.2.3.2. Embryonic Stem Cells (ESCs)
6.2.3.3. Mesenchymal Stem Cells (MSCs)
6.2.4. Hybridoma Cells
6.2.5. Others (e.g., Insect Cells, Primary Cells)
Chapter 7. Cell Banking Outsourcing Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Biologics Manufacturin
7.2.2. Cell & Gene Therapy
7.2.3. Vaccine Production
7.2.4. Tissue Engineering
7.2.5. Regenerative Medicine
7.2.6. Research and Development
7.2.7. Others
Chapter 8. Cell Banking Outsourcing Market Segmentation 4: By Service Type, Estimates & Trend Analysis
8.1. Market Share by Service Type, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Service Type:
8.2.1. Cell Line Characterization & Testing
8.2.2. Cryopreservation & Storage
8.2.3. Cell Line Expansion & Banking
8.2.4. Biosafety Testing (Sterility, Mycoplasma, Adventitious Agents)
8.2.5. Regulatory Support (CMC Documentation, Release Testing)
8.2.6. Others
Chapter 9. Cell Banking Outsourcing Market Segmentation 5: By Phase, Estimates & Trend Analysis
9.1. Market Share by Phase, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Phase:
9.2.1. Preclinical
9.2.2. Clinical
9.2.2.1. Phase I
9.2.2.2. Phase II
9.2.2.3. Phase III
9.2.3. Commercial
Chapter 10. Cell Banking Outsourcing Market Segmentation 6: By End Use, Estimates & Trend Analysis
10.1. Market Share by End Use, 2024 & 2034
10.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End Use:
10.2.1. Biopharmaceutical Companies
10.2.2. Contract Development and Manufacturing Organizations (CDMOs)
10.2.3. Academic & Research Institutions
10.2.4. Cell Therapy Companies
10.2.5. Others
Chapter 11. Cell Banking Outsourcing Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. Global Cell Banking Outsourcing Market, Regional Snapshot 2024 & 2034
11.2. North America
11.2.1. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
11.2.1.1. US
11.2.1.2. Canada
11.2.2. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Bank Type, 2021-2034
11.2.3. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Cell Type, 2021-2034
11.2.4. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
11.2.5. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
11.2.6. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
11.2.7. North America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
11.3. Europe
11.3.1. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
11.3.1.1. Germany
11.3.1.2. U.K.
11.3.1.3. France
11.3.1.4. Italy
11.3.1.5. Spain
11.3.1.6. Rest of Europe
11.3.2. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Bank Type, 2021-2034
11.3.3. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Cell Type, 2021-2034
11.3.4. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
11.3.5. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
11.3.6. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
11.3.7. Europe Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
11.4. Asia Pacific
11.4.1. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
11.4.1.1. India
11.4.1.2. China
11.4.1.3. Japan
11.4.1.4. Australia
11.4.1.5. South Korea
11.4.1.6. Hong Kong
11.4.1.7. Southeast Asia
11.4.1.8. Rest of Asia Pacific
11.4.2. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Bank Type, 2021-2034
11.4.3. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Cell Type, 2021-2034
11.4.4. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
11.4.5. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
11.4.6. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
11.4.7. Asia Pacific Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
11.5. Latin America
11.5.1. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
11.5.1.1. Brazil
11.5.1.2. Mexico
11.5.1.3. Rest of Latin America
11.5.2. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Bank Type, 2021-2034
11.5.3. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Cell Type, 2021-2034
11.5.4. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
11.5.5. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
11.5.6. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
11.5.7. Latin America Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
11.6. Middle East & Africa
11.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
11.6.1.1. GCC Countries
11.6.1.2. Israel
11.6.1.3. South Africa
11.6.1.4. Rest of Middle East and Africa
11.6.2. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Bank Type, 2021-2034
11.6.3. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Cell Type, 2021-2034
11.6.4. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
11.6.5. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
11.6.6. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Phase, 2021-2034
11.6.7. Middle East & Africa Cell Banking Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by End Use, 2021-2034
Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles
12.2.1. AGC Biologics
12.2.1.1. Business Overview
12.2.1.2. Key Product/Service Overview
12.2.1.3. Financial Performance
12.2.1.4. Geographical Presence
12.2.1.5. Recent Developments with Business Strategy
12.2.2. Aldevron
12.2.3. BioReliance (Merck KGaA)
12.2.4. BioOutsource (Sartorius)
12.2.5. Cell and Gene Therapy Catapult
12.2.6. Charles River Laboratories
12.2.7. Eurofins Scientifi
12.2.8. Fujifilm Diosynth Biotechnologies
12.2.9. Lonza Group
12.2.10. Novartis Contract Manufacturing
12.2.11. Paragon Bioservices (Catalent)
12.2.12. Porton Advanced
12.2.13. QTP Labs
12.2.14. Rentschler Biopharma
12.2.15. Samsung Biologics
12.2.16. Sino Biological
12.2.17. Syngene International
12.2.18. Thermo Fisher Scientific (Patheon)
12.2.19. Vibalogics
12.2.20. WuXi Advanced Therapies (WuXi AppTec)
Cell Banking Outsourcing Market by Service Type
· Cell Line Expansion & Banking
· Cell Line Characterization & Testing
· Cryopreservation & Storage
· Regulatory Support
o CMC Documentation
o Release Testing
· Biosafety Testing
o Sterility
o Mycoplasma
o Adventitious Agents
· Others
Cell Banking Outsourcing Market by Cell Type
· Mammalian Cells
o CHO Cells
o BHK Cells
o Vero Cells
o HEK 293 Cells
o Others
· Stem Cells
o Induced Pluripotent Stem Cells (iPSCs)
o Mesenchymal Stem Cells (MSCs)
o Embryonic Stem Cells (ESCs)
· Microbial Cells
o Yeast Cells
o E. coli
o Others
· Hybridoma Cells
· Others (e.g., Insect Cells, Primary Cells)
Cell Banking Outsourcing Market by Bank Type
· Research Cell Bank (RCB)
· Master Cell Bank (MCB)
· End-of-Production Cell Bank (EOPCB)
· Working Cell Bank (WCB)
· Others (e.g., Parental Cell Bank, Stability Cell Bank)
Cell Banking Outsourcing Market by Application
· Vaccine Production
· Cell & Gene Therapy
· Tissue Engineering
· Biologics Manufacturing
· Regenerative Medicine
· Research and Development
· Others
Cell Banking Outsourcing Market by Phase
· Preclinical
· Clinical
o Phase I
o Phase II
o Phase III
· Commercial
Cell Banking Outsourcing Market by End-use
· Biopharmaceutical Companies
· Contract Development and Manufacturing Organizations (CDMOs)
· Cell Therapy Companies
· Academic & Research Institutions
· Others
Cell Banking Outsourcing Market by Region
North America-
· The US
· Canada
Europe-
· Germany
· The UK
· France
· Italy
· Spain
· Rest of Europe
Asia-Pacific-
· China
· Japan
· India
· South Korea
· Southeast Asia
· Rest of Asia Pacific
Latin America-
· Brazil
· Argentina
· Mexico
· Rest of Latin America
Middle East & Africa-
· GCC Countries
· South Africa
· Rest of the Middle East and Africa
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
